treatment of rats with the dopaminergic ergot alkaloid bromocriptine ( brc ) inhibited the following immune reactions : contact sensitivity skin reaction to dinitrochlorobenzene ( dncb ) ;
C0014707
ergot alkaloid
C0006230
bromocriptine